WSTAM
AVNS

Wilbanks Smith & Thomas Asset Management’s Avanos Medical AVNS Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-262
Closed -$18K – 425
2018
Q3 		$18K Buy
+262
New +$16.9K ﹤0.01% 908

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's AVNS Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 262 shares — an estimated $18K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in AVNS in Q3 2018 and held it in 1 quarter. The position peaked at $18K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 262 Avanos Medical shares in Q4 2018, an estimated $18K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Avanos Medical in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Avanos Medical position peaked at $18K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.